Flow Cytometry of Solid Tumours

The current chapter describes the potential application of flow cytometry in various solid tumours. DNA content analysis and synthetic phase evaluation are often helpful to assess the prognosis of the tumour. The simultaneous use of EpCAM and other epithelial markers in flow cytometry (FCM) may detect micrometastasis of carcinoma in the lymph node. The various oncogenic markers and hormone receptors of the solid tumour can be studied in FCM. A panel of antibodies may detect the exact typing of the malignant round cell tumour by flow cytometry.